Inventor
Steven SPARKS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes14%
C08LCompositions of macromolecular compounds14%
E04DRoof coverings14%
PatentTitleYear
12,571,213Asphalt shingle waste-filled polymer-modified asphalt coatings and related systems and related methods202612,458,642Metalloenzyme inhibitor compounds202512,358,893Metalloenzyme inhibitor compounds202511,920,037Rubber-containing asphalt compositions and related methods202411,919,883Metalloenzyme inhibitor compounds202411,136,309Metalloenzyme inhibitor compounds2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to PHASEBIO PHARMACEUTICALS INC (1)· patent assignee history
2021–2026Based in US· patent location history
2024–2025Patents assigned to JI XING PHARMACEUTICALS HONG KONG LTD (2)· patent assignee history
2024Patents assigned to BMIC LLC (1)· patent assignee history
2025Patents assigned to CORXEL PHARMACEUTICALS HONG KONG LTD (2)· patent assignee history
2026Patents assigned to BMRC LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CORXEL PHARMACEUTICALS HONG KONG LTD | 2 | 2025 |
| JI XING PHARMACEUTICALS HONG KONG LTD | 2 | 2024–2025 |
| BMIC LLC | 1 | 2024 |
| BMRC LLC | 1 | 2026 |
| PHASEBIO PHARMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2026 |